首页> 外文期刊>Journal of pharmaceutical sciences. >Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend.
【24h】

Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend.

机译:药物-聚合物相互作用及其对硝苯地平无定形分散体在甲基丙烯酸铵共聚物和乙基纤维素二元共混物微粒中的物理稳定性的意义。

获取原文
获取原文并翻译 | 示例
       

摘要

Using spectroscopic and thermal analysis, this study investigated drug-polymer interaction and its significance on the physical stability of drug amorphous dispersion in microparticles of an ammonio polymethacrylate copolymer (Eudragit RL) (RL) and ethylcellulose (EC) binary blend (RL/EC = 2:1 w/w) prepared for use in controlled release of poorly water-soluble drugs. Solid dispersion of the model drug, nifedipine in the microparticles could be described as an ideal amorphous mixture for drug loadings up to 11% w/w. The antiplasticizing effect of the polymer blend was indicated by a significant increase in the glass transition point from approximately 50 degrees C for the amorphous nifedipine to approximately 115 degrees C for its solid solution. Moreover, shifts in infrared vibration wavenumber of nifedipine carbonyl and amine groups suggested that the hydrogen bonds (H-bonds) originally formed among nifedipine molecules were broken and replaced by those formed between nifedipine and polymers in the microparticles. Further infrared analysis on nifedipine amorphous dispersions with a single polymer, namely RL or EC, confirmed the proposed hydrogen-bonding interactions; and their stability study results suggested that both antiplasticizing effects and hydrogen bonding of EC and RL with nifedipine might be responsible for the physical stability of the microparticles of nifedipine amorphous dispersion with a RL/EC binary blend.
机译:本研究使用光谱和热分析方法研究了药物-聚合物相互作用及其对聚甲基丙烯酸铵共聚物(Eudragit RL)(RL)和乙基纤维素(EC)二元共混物(RL / EC = 2:1 w / w)用于控制释放水溶性差的药物。模型药物硝苯地平在微粒中的固体分散体可描述为药物载量高达11%w / w的理想无定形混合物。玻璃化转变温度从无定形硝苯地平的大约50摄氏度到固溶体的大约115摄氏度的显着增加表明了聚合物共混物的抗塑化作用。此外,硝苯地平羰基和胺基团的红外振动波数的变化表明,最初在硝苯地平分子之间形成的氢键(H键)被打破,并被硝苯地平与微粒中的聚合物之间形成的氢键取代。硝苯地平无定形分散体与单一聚合物(即RL或EC)的进一步红外分析证实了拟议的氢键相互作用。其稳定性研究结果表明,EC和RL与硝苯地平的抗塑作用以及氢键可能与RL / EC二元共混物硝苯地平无定形分散体的微粒的物理稳定性有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号